RJT
BIVV

Raymond James Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Raymond James Trust’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,072
Closed -$328K – 771
2017
Q4 		$328K Buy
6,072
+855
+16% +$46.8K 0.02% 514
2017
Q3 		$297K Buy
+5,217
New +$306K 0.02% 540

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Raymond James Trust's BIVV Position: Q1 2018 in Review

Raymond James Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 6,072 shares — an estimated $328K sold.

Raymond James Trust first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $328K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Raymond James Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Raymond James Trust sold 6,072 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $328K.
  • Raymond James Trust first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Raymond James Trust's Bioverativ Inc. Common Stock position peaked at $328K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Raymond James Trust's 13F filing for Q1 2018, filed 5 Apr 2018.